We are encouraged by the EU’s statement on medicines availability in Northern Ireland, though of course we await the final outcome of the negotiations. We have been talking to the government, the MHRA and other stakeholders about these issues for months, highlighting the concerns of our members in Northern Ireland.
Earlier this year the NPA issued an appeal to negotiators to reach an understanding that will allow manufacturers and suppliers to continue to supply medicines as normal.
Our concern has always been that additional costs and complexity of getting medicines into Northern Ireland could result in some manufacturers and suppliers not bringing products to the market, leading to medicine shortages and an increase in procurement costs. Manufacturers have been informing the government of their intention to withdraw hundreds of medicines from the market in Northern Ireland.